This story is from an installment of The Oeno Files, our weekly insider newsletter to the world of fine wine. Sign up here. In Napa’s neighbor to the south, Silicon Valley has long embraced the ...

However, even though Dragon Ball Super has now seemingly taken Merus off of the game board, the character’s introduction seems too significant to be a simple one-off. Given everything we’ve learned ...

That revelation has sparked some major Dragon Ball Super fan theories about Merus’ origins – and one f the prevailing ones just might hit the nail on the head! The basic premise of this theory is that ...

Merus N.V. (NASDAQ:MRUS), a clinical-stage biopharmaceutical company specializing in targeted oncology antibody assets, has recently been the subject of significant market attention due to its pending ...

Merus (MRUS) has seen its shares surge over the past month, attracting attention from investors who are curious about what has been driving this momentum. The biotech firm’s performance has raised ...

Merus (MRUS) keeps catching attention as its shares post impressive gains over the past month, rising around 46%. Recent investor interest appears closely linked to ongoing optimism around the company ...

Collaboration designed to leverage Merus’ Biclonics ® bispecific antibody technology to expand Incyte’s discovery capabilities and large-molecule portfolio Incyte to make up-front payment of $120 ...

Merus N.V. (NASDAQ:MRUS) shares are trading higher Friday after the company reported promising interim results from its ongoing phase 2 trial evaluating petosemtamab in combination with pembrolizumab ...

Shares of Merus N.V. (NASDAQ:MRUS) are trading higher Tuesday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to petosemtamab in combination with ...